Maruti plans capacity expansion of 1 million vehicles per year

on 23/06/2023

Maruti Suzuki India Ltd (MRTI.NS) has said it plans to ramp up capacity to meet demand for passenger vehicles in the country and abroad, after strong sales in the segment helped the carmaker top quarterly estimates.
Indians bought a record 4 million passenger vehicles in fiscal year 2022-23, led by demand for sports utility vehicles.
Maruti’s results are seen as a key indicator of private consumption in India. The auto sector carries more than 50% weightage in calculating the country’s economic growth.
India’s biggest carmaker said it plans to create additional production capacity of up to one million vehicles per year, adding that its existing capacity of 1.3 million units is fully utilized.
Maruti plans to introduce six different models of electric vehicles by the end of 2030, and these will largely be in the SUV category, chairman R.C. Bhargava said in a post-earnings call.
The company aims to expand its market share to nearly 50% in the passenger vehicles (PV) segment by focusing on utility as well as electric vehicles, Bhargava said.
It currently has more than 40% market share the PV segment.
However, demand for small cars is likely to be stagnant in 2023-24, the chairman added.
Maruti’s profit for quarter ended March rose nearly 43% to 26.24 billion rupees ($321.2 million), beating analyst expectations for 25.70 billion rupees.
Relatively better sales volume led to improved capacity utilization, driving higher margins, Maruti said in a statement, adding that it saw improved price realization, as well as favorable foreign exchange.
Net sales increased about 21% to 308.22 billion rupees.

Concepts and Applications of bio-nanotechnology

on 23/06/2023

Bio-nanotechnology uses a lot of scientific ideas that come from different disciplines. To develop new technologies, bio-nanotechnology heavily relies on the same biochemical principles that are used to comprehend the physical characteristics of biological systems. Mechanical (e.g., deformation, adhesion, failure), electrical/electronic (e.g., electromechanical stimulation, capacitors, energy storage/batteries), optical (e.g., absorption, luminescence, photochemistry), thermal (e.g., thermomutability, thermal management), and biological (e.g., how cells interact with nanomaterials, molecular flaws/defects, bio-sensing, biological mechanisms like mechanosen.
Nanorobots and biological machines are included in the field and are highly helpful tools for expanding this body of knowledge. Researchers have made significant advancements in the past several years in the many tools and systems needed to create functional nanorobots, such as magnetic guiding and mobility. In the future, cancer patients may be offered an alternative to chemotherapy, which has side effects like hair loss, fatigue, and nausea while also killing healthy cells, in order to treat diseases like cancer. This suggests a new approach to treating and managing diseases like cancer. Thanks to nanorobots, side effects of chemotherapy may be controlled, reduced, or even eliminated. Nanobots could be employed for numerous treatments, operations, diagnoses, and imaging in the medical field. The majority of the fundamentals used in nano-biotechnology come from nanotechnology. The majority of the nano-biotechnological gadgets are based directly on other nanotechnologies that are already in use. When it comes to the overlapping multidisciplinary activities connected to biosensors, particularly where photonics, chemistry, biology, biophysics, nanomedicine, and engineering merge, the term “nanobiotechnology” is frequently employed. Another illustration is wave guide measurement in biology, such as dual-polarization interferometry.
The easiest way to sum up the role of nano-biotechnology also known as nanobiology in medicine is to say that it enables current medicine to advance from treating symptoms to developing treatments and restoring biological tissues. Although nanobiology is still in its infancy, many promising techniques could eventually use it. Nanoscience and biology must work together to produce bio-macromolecules and molecular machineries that are similar to those found in nature since biological systems are essentially nano in scale. The convergent fields of nanobiotechnology must overcome an enormous obstacle to control and duplicate the devices and processes made by molecules. Humans can be viewed as nanofoundries, along with all other living things.
Nanobiotechnology and bionanotechnology are distinct from one another in that the former uses biological materials or components, whilst the latter either does so in practice or may theoretically do so. It has a more limited impact on medicine (which is concerned with biological organisms). Instead of focusing on applications that are primarily related to biology, it uses natural or biomimetic systems or elements to create novel nanoscale structures and other applications. Contrarily, nanobiotechnology employs biotechnology that has been scaled down to the nanoscale range or integrates nanomolecules into biological systems. In some applications in the future, both fields might be combined.
The most significant goals that are commonly found in nanobiology entail developing applications for nanotools to pertinent biological and medical issues. Another key goal of nanotechnology is the creation of novel instruments, such as peptoid nanosheets, for biological and medicinal applications. The applications of existing nanotools are frequently improved in order to create new ones. Another important area of study for researchers in nanobiology is the imaging of native biomolecules, biological membranes, and tissues. The use of cantilever array sensors and the use of nanophotonics for controlling molecular processes in living cells are other subjects in nanobiology.

US sanctions will not halt rise of China’s chip industry

on 23/06/2023

While China’s semiconductor capabilities in no way compare to those of Taiwan, the Netherlands or the U.S. at present, it is hardly starting from ground zero.
Since the start of Beijing’s Made in China 2025 initiative in 2015, Chinese companies have made varying degrees of headway across the semiconductor ecosystem. At this point, it seems likely that China will slip its U.S. chokehold in short order, with its chip industry eventually emerging little worse for wear.
Chinese companies today represent 20% of the world’s fabless chip design houses and 10% of the overall global chipmaking capacity, according to the Brookings Institution. China’s 9% share of 2020 global chip sales, according to Semiconductor Industry Association data, placed it ahead of Taiwan and just behind the 10% captured by both the EU and Japan.
The controls the administration of U.S. President Joe Biden announced last October would apply to technologies to make what are known as 14 nanometer or 16 nm chips, as well as more advanced chips, which are referenced by even shorter lengths. The intention is to restrain China’s advances in artificial intelligence, quantum computing and ballistic missile development.
But there are signs that China could already be well on its way to producing sub-14 nm chips. Semiconductor Manufacturing International Corp. (SMIC), China’s largest contract chip producer, last year appeared to successfully produce 7 nm chips although a lack of detail regarding the breakthrough has led to questions about whether the production is commercially sustainable.
SMIC is not the only Chinese company claiming such feats. Huawei Technologies, which has been subject to the most intense U.S. restrictions, late last year filed for a patent for lithographic technology, which is critical for producing advanced chips.
If budgets were the key measure of success, then China would probably be in first place. Under the CHIPS and Science Act, passed last year, the U.S. is funneling $52.7 billion into building, modernizing and expanding domestic chip production. The EU is mulling a plan to invest $46 billion.
But even combined, these amounts pale in comparison to the 1 trillion yuan ($146 billion) package that China is said to be preparing.
To get CHIPS Act aid, companies will need to meet a host of conditions, including, crucially, not expanding semiconductor capacity in “foreign countries of concern for 10 years” and also must not “knowingly engage in any joint research technology licensing effort with a foreign entity of concern that involves sensitive technologies or products.”
The key country of concern, of course, is China. The Biden administration, in effect, is asking companies to choose between the world’s two biggest economies.
Most chip producers have been heavily involved in China for many years. Taiwan Semiconductor Manufacturing Co. (TSMC) and Samsung Electronics, for instance, have been investing billions of dollars in their factories in China.
Despite support from U.S. President Joe Biden, in tie, Taiwan Semiconductor Manufacturing Co. will find it challenging to build a vertically integrated semiconductor ecosystem for its new factory in the state of Arizona. © Reuters
When Nancy Pelosi, then the speaker of the U.S. House of Representatives, visited Taiwan last year, Morris Chang, TSMC’s founder and former chairman, is said to have told her that Washington’s efforts to become a semiconductor powerhouse are naive and doomed to fail.
Chang may have been referring to the complexities of building a vertically integrated semiconductor ecosystem by 2024, when TSMC’s first factory in the state of Arizona is scheduled for completion. It has taken TSMC over 30 years to foster, nurture, and trust its 2,500-odd top-tier suppliers and more than 10,000 secondary suppliers, many of which are based in China.
The notoriously difficult supply chain for chipmaking may work in China’s favor.
Chipmaking entails coordinating myriad unrelated resources and advanced technologies including raw silicon ingots and rare earth metals from China and neon gas from Ukraine, along with specialty chemicals, processing and testing tools, lasers, vacuum sealers and power supplies from all corners of the world.
Combined, the logistical hoops make the Arizona plant’s planned 2024 start date a flat-out impossibility.
Moreover, export controls will not affect China’s 30-year head start in nurturing its stockpile of rare earth metals, skilled chip designers and engineers, and thousands of indigenous suppliers.
Though still behind the world leaders in chip technology, China has proved over time that it can turn fledging industries — whether in high-speed rail, telecommunications, electric vehicles or social media — into juggernauts.
If the U.S. sanctions on Huawei are an indication of the future, then Biden’s chip controls are doomed to fail. The Trump administration in 2020 banned companies from supplying Huawei with custom chips using American software or hardware.
This virtually wiped out Huawei’s once-dominant position in the world’s handset market. Many wrote Huawei off as dead, but it has hardly disappeared. It remains the world’s largest provider of telecommunications equipment while also developing new lines of business, such as creating artificial intelligence applications for governments, phone companies and other businesses.
Biden’s sanctions more than likely will follow a similar path toward obsolescence. The embargo, while seemingly onerous, gives an undeterred Beijing the impetus to garner homegrown technological know-how, muster hundreds of billions of dollars and cultivate a supply chain to catapult an underrated semiconductor ecosystem to new heights.
In the end, the new sanctions are just too little, too late to stop China’s momentum.

Balochistan varsity in financial crisis, JAC demands release of funds

on 23/06/2023

Joint Action Committee, Balochistan University, Teachers, Officers and Employees Association has demanded of the authorities to release Rs1.11 billion by June 2023 to pull the University of Balochistan out of financial crisis and constitute a committee headed by Minister for Finance, Balochistan by giving representation to all the stakeholders of the university.
These demands were made by Professor Fareed Khan Achakzai and Shah Ali Bughti, leaders of the Joint Action Committee, Balochistan University, Teachers, Officers, and Employees Association while addressing a press conference at Quetta Press Club this week.
They said the incumbent Vice Chancellor, the University of Balochistan, had been posted against merit; resultantly, the university had been facing severe educational, economic, and administrative problems owing to the flawed policies of the Vice Chancellor.
They said that academicians, officers, and employees of the university had not been paid their monthly salaries for the last three months. They said that they were on strike for the last one and half months, demanding the authorities get their monthly salaries released, but the concerned authorities were not paying heed to their demand.
They called on the authorities to release an amount of Rs1.11 billion by June 2023 in order to pull University out of financial crises and constitute a committee headed by the Minister for Finance Balochistan by giving representation to all the stakeholders of the university.

A Future with Bioengineering: UIT University Hosts National Symposium

on 23/06/2023

UIT University organized a one-day Symposium on Saturday 29th April, In the symposium guest speakers highlighted the recent developments in Genetic and Bio-engineering that are likely to bring drastic changes to society in the near future, much like how computer technology has transformed the world.
The symposium brings together scientists, technologists, educationalists, students, and entrepreneurs to deliberate some of the amazing challenges and opportunities that are being unfolded with “Gene-editing”, “Synthetic biology” and “Engineering with biology”.
The First National Symposium on Bio-Engineering, a full-day event with 18 distinguished speakers with foreign training, leading the discussions, covered application areas such as Agriculture, Health Sciences, and Engineering Materials. Educationalists proposed steps needed to introduce the subject at the school and college level, whereas business leaders were invited to explore economic opportunities for new startups and businesses.
While addressing the symposium Chancellor of UIT University Mr. Hussain Hasham said that the World is changing very fast with new technologies that’s why UIT University is thinking about immerging in the new field of BioScience, Biotechnology, and bio Engineering.
Sameer Hoodbhoy, Parvez Hoodbhoy, Dr. Athar Asama, Dr. Zahra Hasan, Dr. Shahpar Mirza, and Dr. Stephen Lyone were the guests at the symposium.